If you need more lookups,
subscriptions start at $34 USD/month.
Beverly Bishop Location
Nashville, TN, US
Beverly Bishop Work
2021 -now Senior Medical Science Liaison @
2018 -2021 Executive Medical Science Liaison @
2016 -2018 Senior Medical Science Liaison @
2015 -2016 Senior Medical Science Liaison - Hematology @
2012 -2015 Medical Liaison Ii @
2006 -2012 Oncology Science Liaison @
2005 -2006 Clinical Trial Specialist @ The Smartpill Corporation
2003 -2005 Clinical Research Nurse @
1999 -2003 Nurse 2 @
Beverly Bishop Education
Aspen University
Doctor of Nursing Practice (Nursing)
2020-2022
University of Massachusetts Amherst
Doctor of Philosophy (Nursing, Philosophy)
2012-2015
University of Massachusetts Amherst
Doctor of Nursing Practice (Public Health)
2011-2012
Daemen College 2010
Daemen College
Master of Science (Leadership)
2005-2010
Woodhull Institute for Ethical Leadership 2006
Daemen College
Bachelor of Science
2004
Daemen College
Bachelor of Science in Nursing (Nursing)
2002-2004
Advisory Board Niagara Country Community College 2003
Niagara County Community College
Associate of Arts (Nursing)
1996-1999
University of Massachusetts
Beverly Bishop Summary
Beverly Bishop, based in Nashville, TN, US, is currently a Senior Medical Science Liaison at Mei Pharma. Beverly Bishop brings experience from previous roles at Atara Biotherapeutics, Inc., Exelixis, The Janssen Pharmaceutical Companies of Johnson & Johnson and Actavis PLC (Now Allergan). Beverly Bishop holds a 2020 - 2022 Doctor of Nursing Practice in Nursing @ Aspen University.
Looking for a different Beverly Bishop?
Find contact details for 700 million professionals.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.